21Shares files for Injective ETF amid growing institutional interest

21Shares has filed for an Injective ETF, highlighting the growing interest from institutional investors in digital assets. This move is significant as it reflects the increasing acceptance of cryptocurrencies in mainstream finance, making it easier for large investors to access these markets. As more institutions look to diversify their portfolios with digital assets, this filing could pave the way for more innovative financial products in the future.